ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
Sponsored by Psoriasis Treatment Center of Central New Jersey
About this study
Patient with moderate-to-severe plaque psoriasis will receive Ilumya with or without Halog ointment.
25 adult subjects with moderate to severe plaque psoriasis will receive Ilumya 100mg subcutaneously at weeks 0, 4 and 16. At week 16, patients with remaining BSA ˃3% will be given HALOG ointment 0.1% to apply BID for 4 weeks. Patients who have ≤3% BSA at week 16 will remain on Ilumya monotherapy. Patients will continue to be evaluated at weeks 20 and 24.
Where this study is enrolling
- I'm interested
Psoriasis Treatment Center of Central New Jersey
East Windsor, New Jersey
Who can participate
Inclusion criteria
- ✓1. Male or female adult ≥ 18 years of age;
- ✓2. Diagnosis of moderate-to-severe chronic plaque-type psoriasis as defined by
- ✓BSA 10%
- ✓PGA ≥3
- ✓PASI ≥12
- ✓3. Must be a candidate for phototherapy and/or systemic therapy
- ✓4. Females of childbearing potential (FCBP) must have a negative serum pregnancy test at Screening and negative urine pregnancy test at Baseline. FCBP who engage in activity in which conception is possible must use one of the approved contraceptive options: hormonal contraception; intrauterine device (IUD); tubal ligation; or partner's vasectomy; Male or female condom diaphragm with spermicide, cervical cap with spermicide, or contraceptive sponge with spermicide.
Exclusion criteria
- ✕1. Non-plaque forms of psoriasis
- ✕2. Women of childbearing potential who are pregnant, intend to become pregnant, or are lactating
- ✕3. Presence of significant uncontrolled medical condition that in the opinion of the investigator would affect patient safety during the trial.
- ✕4. Active or untreated latent tuberculosis (TB)
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.